Skip to main content
Caplight Logo









Nevvon

Nevvon

Private
New York City, New YorkHealthcare & Life Scienceshttps://nevvon.com

Last Round

Grant

Feb 17, 2024

Total Funding Raised

$971,600

Company Overview

Nevvon operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Grant round in February 2024.

Nevvon is an educational software company that provides an all-in-one e-training and compliance platform for healthcare agencies and caregivers.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Compliance & Risk, HR

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Nevvon Comparables

Compare Nevvon with similar companies based on industry and business-model similarity.

Nevvon comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Showd.me
87%
CareSmartz360
84%
Activated Insights
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Nevvon Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 17, 2024
GrantJan 1, 2023
SeedJan 1, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Uri Sevilla

Chief Technology Officer

Executive Team

Ashley Wharton

Chief Product Officer

Executive Team

For institutional investors. Book with your work email.

Nevvon Investors

Notable investors and investment history

Nevvon investors
InvestorRounds
HaloHealthSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 9, 2025

    Monthly visitors increased 120% MoM, reaching 429.6K.

  • May 1, 2025

    Monthly visitors grew 256% MoM, reaching 302.6K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Nevvon Filings

Explore SEC and related filing metadata, where available.

Nevvon filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Nevvon's valuation, stock price, and market status.

Is Nevvon a public or private company?

Nevvon is a private company.

What is the current stock price of Nevvon?

Nevvon is a private company, so its shares have no public market price. Caplight tracks Nevvon's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Nevvon worth (valuation)?

Valuation information for Nevvon is not publicly available.

Can I buy Nevvon stock?

Nevvon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Nevvon's last funding round?

Nevvon's most recent funding round was Grant on February 17, 2024.

Who are the main investors in Nevvon?

Key investors in Nevvon include HaloHealth.

Will Nevvon IPO soon?

No public IPO plans have been announced for Nevvon.

How can I track Nevvon secondary market activity?

Caplight tracks bids, offers, and trades in Nevvon's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range56
Year Founded2017
Last FundingFeb 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?